We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Singer Capital Markets are delighted to announce that our client’s RenalytixAI and EKF Diagnostics have won the ‘AIM Transaction of the Year’ Award at the AIM Awards Dinner 2019.
The award was won for RenalytixAI’s IPO on AIM last year, which raised gross funds of £22.25 million on admission. RenalytixAI is a spin out from EKF, the AIM-traded medical diagnostics business.
Singer Capital Markets is acting as Nominated Adviser and Broker to EKF Diagnostics and acted as RenalytixAI’s Nominated Adviser & Broker in relation to their admission to trading.
About The AIM Awards Dinner
The AIM Award Dinner attracts over 1,400 guests each year, including Senior Directors, Nomads, brokers and accountants to celebrate the outstanding achievements on the AIM market. The night identifies the quoted companies and entrepreneurs who have harnessed AIM to help them fulfill their ambitions and growth potential within the previous 12 months.
For more information about this news, please email us or call us on +44 (0)20 7496 3000.
[follow align=”center” twitter=”https://twitter.com/nplus1singer” linkedin=”https://www.linkedin.com/company/274452/”]
